Peng Zhu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Natural Killer Cells

Hepatitis B Virus

Prognostic Factors

Top Venues

Cancer research

Clinical and translational medicine

Journal of hepatocellular carcinoma

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Chen Su, Haoquan Zhang, Jie Mo, Zhibin Liao, Bixiang Zhang, Peng Zhu
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. Clinical and translational medicine 14 (1) (2024)
Chen Su, Haoquan Zhang, Jie Mo, Zhibin Liao, Bixiang Zhang, Peng Zhu
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. Clinical and translational medicine 14 (1) (2024)
Chen Su, Haoquan Zhang, Jie Mo, Zhibin Liao, Bixiang Zhang, Peng Zhu
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. Clinical and translational medicine 14 (1) (2024)
Xulin Liu, Zhancheng Qiu, Elijah Ndhlovu, Yunyan Wan, Huapeng Sun, Shuai Wang, Yugang Cao, Peng Zhu
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study. Journal of hepatocellular carcinoma 11 (2024)
Xulin Liu, Zhancheng Qiu, Elijah Ndhlovu, Yunyan Wan, Huapeng Sun, Shuai Wang, Yugang Cao, Peng Zhu
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study. Journal of hepatocellular carcinoma 11 (2024)
Chen Su, Haoquan Zhang, Jie Mo, Zhibin Liao, Bixiang Zhang, Peng Zhu
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation. Clinical and translational medicine 14 (1) (2024)
Xue Cheng, Xiaosheng Tan, Wei Wang, Ziyao Zhang, Rong-Fei Zhu, Mi Wu, Mingyu Li, Yiqing Chen, Zhihui Liang, Peng Zhu, Xiongwen Wu, Xiufang Weng
Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma. Cancer research 83 (4) (2023)
Xue Cheng, Xiaosheng Tan, Wei Wang, Ziyao Zhang, Rong-Fei Zhu, Mi Wu, Mingyu Li, Yiqing Chen, Zhihui Liang, Peng Zhu, Xiongwen Wu, Xiufang Weng
Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma. Cancer research 83 (4) (2023)
Jingxian Duan, Peng Zhu, Yong Zhang, Tianhao Mu, Yingqiang Li, Rui Xiong, Su Chen, Yingmei Li, Zhi-Cheng Li, Shifu Chen, Lei Zhang
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma. Journal of clinical and translational hepatology 11 (4) (2023)
Xue Cheng, Xiaosheng Tan, Wei Wang, Ziyao Zhang, Rong-Fei Zhu, Mi Wu, Mingyu Li, Yiqing Chen, Zhihui Liang, Peng Zhu, Xiongwen Wu, Xiufang Weng
Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma. Cancer research 83 (4) (2023)
Xue Cheng, Xiaosheng Tan, Wei Wang, Ziyao Zhang, Rong-Fei Zhu, Mi Wu, Mingyu Li, Yiqing Chen, Zhihui Liang, Peng Zhu, Xiongwen Wu, Xiufang Weng
Long-chain acylcarnitines induce senescence of invariant natural killer T cells in hepatocellular carcinoma. Cancer research (2022)
Feng Xia, Elijah Ndhlovu, Zhicheng Liu, Xiaoping Chen, Bixiang Zhang, Peng Zhu
Alpha-Fetoprotein+Alkaline Phosphatase (A-A) Score Can Predict the Prognosis of Patients with Ruptured Hepatocellular Carcinoma Underwent Hepatectomy. Disease markers 2022 (2022)
Feng Xia, Peng Zhu, Xiao-Ping Chen, Bi-Xiang Zhang, Ming-Yu Zhang
Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis. Journal of oncology 2022 (2022)